Table 7.
Prevalence and age at onset of psoriatic comorbidities in EOP and LOP
| Variables | Total patients (N = 160) | EOP (N = 121) | LOP (N = 39) | P |
|---|---|---|---|---|
| CVD, N (%) | 4 (2.5) | 1 (0.8) | 3 (7.7) | 0.045 |
| Age at CVD onset, years | 50.75 ± 2.36 | 51 | 50.67 ± 1.67 | 0.929 |
| mean±SD (range) | (49–54) | 51 | (49–54) | |
| HT, n (%) | 32 (20) | 17 (14) | 15 (38.5) | 0.001 |
| Age at HT onset, years | 44.28 ± 8.23 | 41.53 ± 5.37 | 47.40 ± 9.87 | |
| mean±SD (range) | (33–70) | (33–53) | (39–70) | 0.165 |
| DM, N (%) | 25 (15.6) | 12 (9.9) | 13 (33.3) | < 0.01 |
| Age at DM onset, years | 42.68 ± 9.79 | 37.75 ± 7.70 | 47.23 ± 9.53 | 0.004 |
| mean±SD (range) | (28–65) | (28–57) | (38–65) | |
| NASH, N (%) | 29 (18.1) | 22 (18.2) | 7 (17.9) | 0.974 |
| Age at NASH onset, years | 39.21 ± 8.20 | 37.48 ± 8.34 | 44.43 ± 5.38 | 0.045 |
| mean±SD (range) | (20–59) | (20–59) | (38–53) | |
| DLP, N (%) | 99 (61.9) | 72 (59.5) | 27 (69.2) | 0.392 |
| MS, N (%) | 47 (29.6) | 30 (24.8) | 17 (44.7) | 0.022 |
| OB, N (%) | 46 (28.7) | 36 (29.8) | 10 (25.6) | 0.622 |
CVD = cardiovascular disease; DLP = dyslipidemia; DM = diabetes mellitus; EOP: early onset psoriasis; HT = hypertension; LOP = late onset psoriasis; MS = metabolic syndrome; NASH = non-alcoholic steatohepatitis; OB = obesity; SD = standard deviation.